AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] CVD Equipment Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Dr. Robert M. Brill, a director of CVD Equipment Corp. (CVV), received an automatic grant of 11,100 shares of common stock on 08/08/2025 under the company’s 2022 Share Incentive Plan. The grant was issued at a $0 price and the Form reports his beneficial ownership following the grant as 46,546 shares, held directly.

The award was made pursuant to the Company’s director compensation plan at the 2025 Annual Meeting and will vest in four quarterly installments on 09/30/2025, 12/31/2025, 03/31/2026 and 06/30/2026 provided he remains a director on each vesting date. The Form 4 was signed on 08/12/2025 and was filed by one reporting person; the transaction is recorded as an acquisition (code A).

Dr. Robert M. Brill, direttore di CVD Equipment Corp. (CVV), ha ricevuto in data 08/08/2025 una concessione automatica di 11,100 azioni ordinarie ai sensi del 2022 Share Incentive Plan della società. La concessione è stata emessa a un prezzo di $0 e il modulo riporta la sua titolarità effettiva dopo la concessione pari a 46,546 azioni, detenute direttamente.

Il premio è stato assegnato in base al piano di compensazione per i direttori approvato all'Assemblea Annuale 2025 e maturerà in quattro rate trimestrali il 09/30/2025, 12/31/2025, 03/31/2026 e 06/30/2026, a condizione che rimanga direttore in ognuna delle date di maturazione. Il Modulo 4 è stato firmato il 08/12/2025 e presentato da un unico soggetto segnalante; la transazione è registrata come un'acquisizione (codice A).

Dr. Robert M. Brill, director de CVD Equipment Corp. (CVV), recibió automáticamente el 08/08/2025 una concesión de 11,100 acciones ordinarias en virtud del 2022 Share Incentive Plan de la compañía. La concesión se otorgó a un precio de $0 y el formulario indica su propiedad beneficiaria tras la concesión en 46,546 acciones, mantenidas directamente.

El premio se concedió conforme al plan de compensación de directores aprobado en la Junta Anual 2025 y se consolidará en cuatro pagos trimestrales el 09/30/2025, 12/31/2025, 03/31/2026 y 06/30/2026, siempre que siga siendo director en cada fecha de consolidación. El Formulario 4 fue firmado el 08/12/2025 y presentado por una sola persona informante; la transacción se registra como una adquisición (código A).

Dr. Robert M. BrillëŠ� CVD Equipment Corp. (CVV)ì� ì´ì‚¬ë¡œì„œ 08/08/2025ì—� 회사ì� 2022 Share Incentive Planì—� ë”°ë¼ ìžë™ìœ¼ë¡œ 11,100ì£¼ì˜ ë³´í†µì£¼ë¥¼ 부여받았습니다. ì� 부여는 $0ì� 가격으ë¡� ì´ë£¨ì–´ì¡Œìœ¼ë©°, 서ì‹ì€ ë¶€ì—� í›� ê·¸ì˜ ì‹¤ì†Œìœ ì£¼ 수를 46,546주로, ì§ìΪ 보유하고 있다ê³� 보고하고 있습니다.

ì� 수여ëŠ� 2025ë…� ì—°ë¡€ì´íšŒì—서 승ì¸ë� ì´ì‚¬ 보수 계íšì—� 따른 것으ë¡�, ë„� ë²ˆì˜ ë¶„ê¸°ë³� í• ë¶€ë¡� 권리가 확정ë©ë‹ˆë‹�(09/30/2025, 12/31/2025, 03/31/2026, 06/30/2026)â€”ê° í™•ì •ì¼ì— 여전íž� ì´ì‚¬ë¡� ìž¬ì§ ì¤‘ì¸ ê²½ìš°ì—ë§Œ 해당합니ë‹�. Form 4ëŠ� 08/12/2025ì—� 서명ë˜ì—ˆê³� í•� ëª…ì˜ ì‹ ê³ ì¸ì´ 제출했으ë©�, 거래ëŠ� ì·¨ë“(코드 A)으로 기ë¡ë˜ì–´ 있습니다.

Dr. Robert M. Brill, administrateur de CVD Equipment Corp. (CVV), a reçu automatiquement le 08/08/2025 une attribution de 11,100 actions ordinaires dans le cadre du 2022 Share Incentive Plan de la société. L'attribution a été effectuée à un prix de $0 et le formulaire indique sa détention bénéficiaire après l'attribution à 46,546 actions, détenues directement.

Cette attribution a été faite conformément au plan de rémunération des administrateurs approuvé lors de l'assemblée annuelle 2025 et sera acquise en quatre versements trimestriels les 09/30/2025, 12/31/2025, 03/31/2026 et 06/30/2026, sous réserve qu'il demeure administrateur à chaque date d'acquisition. Le Formulaire 4 a été signé le 08/12/2025 et déposé par une seule personne déclarante ; la transaction est enregistrée comme une acquisition (code A).

Dr. Robert M. Brill, Direktor von CVD Equipment Corp. (CVV), erhielt am 08/08/2025 automatisch eine Zuteilung von 11,100 Stammaktien im Rahmen des 2022 Share Incentive Plan der Gesellschaft. Die Zuteilung erfolgte zu einem Preis von $0 und das Formular gibt seinen wirtschaftlichen Anteil nach der Zuteilung mit 46,546 Aktien an, die direkt gehalten werden.

Die Zuwendung erfolgte gemäß dem Vergütungsplan für Direktoren, der auf der Hauptversammlung 2025 beschlossen wurde, und wird in vier vierteljährlichen Tranchen fällig am 09/30/2025, 12/31/2025, 03/31/2026 und 06/30/2026, vorausgesetzt, er bleibt an jedem Vesting-Datum Direktor. Das Formular 4 wurde am 08/12/2025 unterschrieben und von einer meldenden Person eingereicht; die Transaktion ist als Erwerb (Code A) verbucht.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director received 11,100 shares at $0 on 08/08/2025; vests quarterly and raises direct holdings to 46,546 shares.

The filing documents a routine, automatic director equity grant issued under the company’s disclosed director compensation plan and the 2022 Share Incentive Plan. The award was recorded as an acquisition on 08/08/2025 and carried a reported price of $0. After the grant, beneficial ownership is reported at 46,546 shares held directly. Vesting is contingent on continued service with quarterly vesting dates through 06/30/2026. Impact: 0 (neutral)—the filing is a standard compensation disclosure with no immediate material financial metrics reported.

TL;DR: Grant governed by the 2022 Share Incentive Plan; vesting depends on continued board service across four quarterly dates.

The Form 4 states the grant was automatic following the 2025 Annual Meeting and will vest in four quarterly installments if the recipient remains a director on each vesting date. The reporting person is identified as a Director and the Form was filed by one reporting person. From a governance perspective, the disclosure documents standard director compensation mechanics and service-based vesting conditions. Impact: 0 (neutral)—informational for shareholders but not a material corporate event.

Dr. Robert M. Brill, direttore di CVD Equipment Corp. (CVV), ha ricevuto in data 08/08/2025 una concessione automatica di 11,100 azioni ordinarie ai sensi del 2022 Share Incentive Plan della società. La concessione è stata emessa a un prezzo di $0 e il modulo riporta la sua titolarità effettiva dopo la concessione pari a 46,546 azioni, detenute direttamente.

Il premio è stato assegnato in base al piano di compensazione per i direttori approvato all'Assemblea Annuale 2025 e maturerà in quattro rate trimestrali il 09/30/2025, 12/31/2025, 03/31/2026 e 06/30/2026, a condizione che rimanga direttore in ognuna delle date di maturazione. Il Modulo 4 è stato firmato il 08/12/2025 e presentato da un unico soggetto segnalante; la transazione è registrata come un'acquisizione (codice A).

Dr. Robert M. Brill, director de CVD Equipment Corp. (CVV), recibió automáticamente el 08/08/2025 una concesión de 11,100 acciones ordinarias en virtud del 2022 Share Incentive Plan de la compañía. La concesión se otorgó a un precio de $0 y el formulario indica su propiedad beneficiaria tras la concesión en 46,546 acciones, mantenidas directamente.

El premio se concedió conforme al plan de compensación de directores aprobado en la Junta Anual 2025 y se consolidará en cuatro pagos trimestrales el 09/30/2025, 12/31/2025, 03/31/2026 y 06/30/2026, siempre que siga siendo director en cada fecha de consolidación. El Formulario 4 fue firmado el 08/12/2025 y presentado por una sola persona informante; la transacción se registra como una adquisición (código A).

Dr. Robert M. BrillëŠ� CVD Equipment Corp. (CVV)ì� ì´ì‚¬ë¡œì„œ 08/08/2025ì—� 회사ì� 2022 Share Incentive Planì—� ë”°ë¼ ìžë™ìœ¼ë¡œ 11,100ì£¼ì˜ ë³´í†µì£¼ë¥¼ 부여받았습니다. ì� 부여는 $0ì� 가격으ë¡� ì´ë£¨ì–´ì¡Œìœ¼ë©°, 서ì‹ì€ ë¶€ì—� í›� ê·¸ì˜ ì‹¤ì†Œìœ ì£¼ 수를 46,546주로, ì§ìΪ 보유하고 있다ê³� 보고하고 있습니다.

ì� 수여ëŠ� 2025ë…� ì—°ë¡€ì´íšŒì—서 승ì¸ë� ì´ì‚¬ 보수 계íšì—� 따른 것으ë¡�, ë„� ë²ˆì˜ ë¶„ê¸°ë³� í• ë¶€ë¡� 권리가 확정ë©ë‹ˆë‹�(09/30/2025, 12/31/2025, 03/31/2026, 06/30/2026)â€”ê° í™•ì •ì¼ì— 여전íž� ì´ì‚¬ë¡� ìž¬ì§ ì¤‘ì¸ ê²½ìš°ì—ë§Œ 해당합니ë‹�. Form 4ëŠ� 08/12/2025ì—� 서명ë˜ì—ˆê³� í•� ëª…ì˜ ì‹ ê³ ì¸ì´ 제출했으ë©�, 거래ëŠ� ì·¨ë“(코드 A)으로 기ë¡ë˜ì–´ 있습니다.

Dr. Robert M. Brill, administrateur de CVD Equipment Corp. (CVV), a reçu automatiquement le 08/08/2025 une attribution de 11,100 actions ordinaires dans le cadre du 2022 Share Incentive Plan de la société. L'attribution a été effectuée à un prix de $0 et le formulaire indique sa détention bénéficiaire après l'attribution à 46,546 actions, détenues directement.

Cette attribution a été faite conformément au plan de rémunération des administrateurs approuvé lors de l'assemblée annuelle 2025 et sera acquise en quatre versements trimestriels les 09/30/2025, 12/31/2025, 03/31/2026 et 06/30/2026, sous réserve qu'il demeure administrateur à chaque date d'acquisition. Le Formulaire 4 a été signé le 08/12/2025 et déposé par une seule personne déclarante ; la transaction est enregistrée comme une acquisition (code A).

Dr. Robert M. Brill, Direktor von CVD Equipment Corp. (CVV), erhielt am 08/08/2025 automatisch eine Zuteilung von 11,100 Stammaktien im Rahmen des 2022 Share Incentive Plan der Gesellschaft. Die Zuteilung erfolgte zu einem Preis von $0 und das Formular gibt seinen wirtschaftlichen Anteil nach der Zuteilung mit 46,546 Aktien an, die direkt gehalten werden.

Die Zuwendung erfolgte gemäß dem Vergütungsplan für Direktoren, der auf der Hauptversammlung 2025 beschlossen wurde, und wird in vier vierteljährlichen Tranchen fällig am 09/30/2025, 12/31/2025, 03/31/2026 und 06/30/2026, vorausgesetzt, er bleibt an jedem Vesting-Datum Direktor. Das Formular 4 wurde am 08/12/2025 unterschrieben und von einer meldenden Person eingereicht; die Transaktion ist als Erwerb (Code A) verbucht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BRILL DR ROBERT M

(Last) (First) (Middle)
C/O CVD EQUIPMENT CORPORATION
355 S. TECHNOLOGY DRIVE

(Street)
CENTRAL ISLIP NY 11722

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CVD EQUIPMENT CORP [ CVV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 A 11,100(1) A $0 46,546 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Automatic grant issued on the date of the Company's 2025 Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026) provided that the recipient is still serving as a Director on the respective vesting dates.
/s/ Robert Brill 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 disclose for CVD Equipment Corp (CVV)?

The Form 4 shows Director Dr. Robert M. Brill received an automatic grant of 11,100 common shares on 08/08/2025 under the 2022 Share Incentive Plan.

How many CVV shares does Robert Brill own after the reported transaction?

Following the reported acquisition, his beneficial ownership is listed as 46,546 shares, held directly.

At what price were the CVV shares granted to the director?

The grant is reported with a price of $0 on the Form 4.

When do the granted CVV shares vest?

The grant vests in four quarterly installments on 09/30/2025, 12/31/2025, 03/31/2026 and 06/30/2026, provided the recipient remains a director on each vesting date.

When was the Form 4 signed and filed for CVV?

The signature date on the Form 4 is 08/12/2025, and the transaction date reported is 08/08/2025.
Cvd Equipment

NASDAQ:CVV

CVV Rankings

CVV Latest News

CVV Latest SEC Filings

CVV Stock Data

25.33M
5.30M
23.9%
17.76%
0.14%
Specialty Industrial Machinery
Special Industry Machinery, Nec
United States
CENTRAL ISLIP